Association between serum urate and flares in people with gout and evidence for surrogate status: a secondary analysis of two randomised controlled trials

痛风 医学 内科学 尿酸 别嘌呤醇 物理疗法 随机对照试验 逻辑回归
作者
Lisa K. Stamp,Christopher Frampton,Melanie Birger Morillon,William J. Taylor,Nicola Dalbeth,Jasvinder A. Singh,Michael Doherty,Weiya Zhang,Helen Richardson,Aliya Sarmanova,Robin Christensen
出处
期刊:The Lancet Rheumatology [Elsevier BV]
卷期号:4 (1): e53-e60 被引量:31
标识
DOI:10.1016/s2665-9913(21)00319-2
摘要

Background Use of serum urate as a treatment target and outcome measure has become controversial in view of the 2017 American College of Physicians guidelines, which advocated a treat-to-symptom rather than a treat-to-target serum urate approach to gout management. The relevance of serum urate as a treatment target measure implies that achievement of target serum urate is causally associated with improvement in patient-important outcomes such as reduction in the number of gout flares. The aim of this study was to assess the causal relationship between achieving target serum urate and the occurrence of gout flares. Methods We analysed individual patient-level data from two randomised trials on urate-lowering therapies in people with gout conducted in Nottingham, UK, and New Zealand. We included participants randomly assigned to immediate dose escalation in the New Zealand study and all participants in the Nottingham study (a nurse-led gout care group and a general practitioner-led usual care group). Individuals who on average achieved a serum urate concentration less than 6 mg/dL (0·36 mmol/L) based on data at 6, 9, and 12 months post-baseline were defined as serum urate responders. The primary outcome was the proportion of participants having at least one gout flare, and the secondary outcome was the mean number of flares per participant per month, from 12 to 24 months after baseline, compared between serum urate responders and non-responders. In adjusted logistic regression models, serum urate at baseline, previous flare history (in the year preceding study entry), presence of tophi at baseline, and, for the Nottingham dataset, the original randomisation group, were included as covariates. The Nottingham study was registered with ClinicalTrials.gov, NCT01477346. The New Zealand study was registered with the Australian New Zealand Clinical Trials Registry, ACTRN12611000845932. Findings From the combined individual data from both trials, we identified 343 serum urate responders and 245 serum urate non-responders. Significantly fewer serum urate responders had a gout flare than did serum urate non-responders between 12 and 24 months (91 [27%] of 343 vs 156 [64%] of 245; adjusted odds ratio [OR] 0·29 [95% CI 0·17 to 0·51], p<0·0001). The mean number of flares per participant per month between 12 and 24 months was significantly lower in serum urate responders than in serum urate non-responders (adjusted mean difference –1·41 [95% CI –1·77 to –1·04], p<0·0001). This association was independent of the original randomised treatment allocation. Interpretation Achieving an average serum urate concentration less than 6 mg/dL is associated with an absence of gout flares and a reduction in the number of flares in the subsequent 12 months in people with gout. These results support a treat-to-target serum urate approach in the management of gout. Funding None.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
话家发布了新的文献求助10
刚刚
zygclwl发布了新的文献求助10
刚刚
香蕉觅云应助标致冬日采纳,获得10
刚刚
喜看财经发布了新的文献求助10
刚刚
kk完成签到 ,获得积分10
刚刚
啥也不会完成签到,获得积分10
刚刚
忧郁元柏完成签到,获得积分10
1秒前
大宝完成签到,获得积分10
1秒前
嘟嘟金子完成签到,获得积分10
1秒前
2秒前
初宏翔发布了新的文献求助10
2秒前
阿祖完成签到,获得积分10
4秒前
Jun完成签到 ,获得积分10
4秒前
甜蜜屁池完成签到,获得积分10
4秒前
辛勤安梦完成签到,获得积分10
4秒前
hindbind完成签到,获得积分10
5秒前
5秒前
5秒前
务实鞅完成签到 ,获得积分10
5秒前
FIN应助zhc采纳,获得30
5秒前
田様应助tuzhihong采纳,获得10
5秒前
奋斗冬萱发布了新的文献求助10
6秒前
阳光的牛牛完成签到,获得积分10
6秒前
叶液发布了新的文献求助30
7秒前
松松包完成签到,获得积分10
7秒前
不胜寒完成签到,获得积分10
7秒前
CodeCraft应助wqkkk采纳,获得10
8秒前
芝芝完成签到,获得积分10
8秒前
自觉画笔完成签到 ,获得积分10
8秒前
duonicola完成签到,获得积分10
8秒前
初宏翔完成签到,获得积分10
8秒前
orixero应助落后的早晨采纳,获得10
8秒前
妍宝贝完成签到 ,获得积分10
8秒前
Orange应助如风随水采纳,获得10
9秒前
海豚发布了新的文献求助10
9秒前
云淡风轻完成签到,获得积分10
9秒前
难过的小甜瓜完成签到,获得积分10
9秒前
liaomr发布了新的文献求助10
10秒前
饼饼完成签到,获得积分10
10秒前
烟花应助无语的冬易采纳,获得10
10秒前
高分求助中
The Mother of All Tableaux Order, Equivalence, and Geometry in the Large-scale Structure of Optimality Theory 2400
Ophthalmic Equipment Market by Devices(surgical: vitreorentinal,IOLs,OVDs,contact lens,RGP lens,backflush,diagnostic&monitoring:OCT,actorefractor,keratometer,tonometer,ophthalmoscpe,OVD), End User,Buying Criteria-Global Forecast to2029 2000
Optimal Transport: A Comprehensive Introduction to Modeling, Analysis, Simulation, Applications 800
Official Methods of Analysis of AOAC INTERNATIONAL 600
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 588
Residual Stress Measurement by X-Ray Diffraction, 2003 Edition HS-784/2003 588
T/CIET 1202-2025 可吸收再生氧化纤维素止血材料 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3950088
求助须知:如何正确求助?哪些是违规求助? 3495487
关于积分的说明 11077296
捐赠科研通 3226021
什么是DOI,文献DOI怎么找? 1783386
邀请新用户注册赠送积分活动 867687
科研通“疑难数据库(出版商)”最低求助积分说明 800855